A new startup incubator has just opened in Manhattan this morning, adding to a growing list of facilities meant to help support seedling New York City biotechs. LaunchLabs, first announced by Alexandria Real Estate Equities a year ago, officially opened its doors and revealed the 13 startups that will grow there. LaunchLabs is a 15,000-square-foot […]
NYS Entity Status
NYS Filing Date
MARCH 22, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2013 - ALTERI'S LANDSCAPING & SNOW PLOWING, LLC
Around the Web
- Alexandria Debuts NY’s Latest Bio Incubator With 13 Startups in Tow
By Ben Fidler - Tuesday Jun 13, 2017
- That 'racist' meme of Samuel L. Jackson and Magic Johnson in Italy isn't what it seems
By Gianluca Mezzofiore - Tuesday Aug 22, 2017
It's certainly a zany story with a catchy headline — Italians mistake actor Samuel L. Jackson and legendary basketball player Magic Johnson for "lazy migrants." But there's much more to the story than a clickbaity title, and it taps into a widespread debate on populism, racism, and immigration.
It all started when left-wing satirical writer Luca Bottura posted on Facebook a meme of Jackson and Johnson on holiday in Forte dei Marmi for what he later described as a "social experiment"— in a nutshell, to troll migrant-haters in the country. Read more...More about Italy, Meme, Migrants, Samuel L. Jackson, and Magic Johnson
- The Annie Leibovitz of the Alt-Right
By MATTHEW KASSEL - Thursday Jul 20, 2017
The photographer Peter Duke is on a mission to make reactionaries look glamorous.
- In the Huddle With NY Jets Owner Woody Johnson
Friday Oct 15, 2010
Woody Johnson, owner of the New York Jets NFL franchise, joins WSJ's Lee Hawkins for the "WSJ Weekend Conversations" series to talk about the Jets' Super Bowl prospects, co-chairing the 2014 Super Bowl host committee, and his charitable interests.
- J&J’s Gorsky on Regulation of ‘Biosimilars’
Thursday Sep 29, 2016
Johnson & Johnson Chairman and CEO Alex Gorsky speaks with WSJ’s Laura Landro about the increased regulatory environment and the role of ‘biosimilar’ drugs in the pharma landscape.